It is known that dopamine acts as a circadian clock input, enhancing the transcription of the CLOCK:BMAL-1 complex via the activation of dopamine receptors in the nervous system (including in the SCN) [167–169], however much more extensive mechanistic studies are required to completely characterize clock gene expression and potential regulatory mechanisms in PD. This evidence concerns the gene BMAL1 and Parkinson disease.